secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACADIA PHARMACEUTICALS INC (ACAD)
CIK:        0001070494
Form:       8-K
Filed at:   2024-01-31T23:59:59+00:00
Accession:  0001193125-24-019903
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Acadia EVP, General Counsel Austin Kim departs; transition period
-----------------------------------------------------------------

- Austin D. Kim, Executive VP, General Counsel & Secretary, leaves Acadia to pursue other opportunities.
- Mr. Kim will remain a non-executive employee during a transition period to assist with orderly handover.
- No successor has been named as of the announcement date (January 30, 2024).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070494/000119312524019903/0001193125-24-019903-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070494/000119312524019903/d113006d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-019903

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer